Literature DB >> 22772326

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.

Susan J Bartlett1, Sarah Hewlett, Clifton O Bingham, Thasia G Woodworth, Rieke Alten, Christoph Pohl, Ernest H Choy, Tessa Sanderson, Annelies Boonen, Vivian Bykerk, Amye L Leong, Vibeke Strand, Daniel E Furst, Robin Christensen.   

Abstract

OBJECTIVE: For rheumatoid arthritis (RA), there is no consensus on how to define and assess flare. Variability in flare definitions impairs understanding of findings across studies and limits ability to pool results. The OMERACT RA Flare Group sought to identify domains to define RA flares from patient and healthcare professional (HCP) perspectives.
METHODS: Flare was described as a worsening of disease activity of sufficient intensity and duration to consider a change in therapy. International patients and HCPs participated in separate and combined rounds of Delphi exercises to rate candidate flare domains previously generated in patient focus groups. Core domains were defined as those with ≥70% ratings of being 'essential' according to the third/final Delphi exercise.
RESULTS: The final Delphi included 125 RA patients from 10 countries and 108 HCPs from 23 countries who rated 14 domains. Patients had a mean (±SD) age of 56±12 years and disease duration of 18±12 years. HCPs included physicians from clinical practice/research and industry, allied health providers and researchers with 17±11 years experience. Core domains comprised: pain (93%), function (89%), swollen joints (84%), tender joints (81%), participation (81%), stiffness (79%), patient global assessment (76%) and self-management (75%). Fatigue (68%), which did not reach group consensus, will receive additional consideration.
CONCLUSIONS: As part of the process to develop a measure for RA flare, patients and HCPs agreed on eight core domains. Next steps include identifying items to assess domains and conducting studies to validate and refine a new measure.

Entities:  

Mesh:

Year:  2012        PMID: 22772326     DOI: 10.1136/annrheumdis-2011-201201

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  60 in total

1.  Identifying key domains of health-related quality of life for patients with chronic obstructive pulmonary disease: interviews with healthcare professionals.

Authors:  Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen
Journal:  Qual Life Res       Date:  2014-11-16       Impact factor: 4.147

Review 2.  More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions.

Authors:  Ana-Maria Orbai; Serena Halls; Sarah Hewlett; Susan J Bartlett; Amye L Leong; Clifton O Bingham
Journal:  J Rheumatol       Date:  2015-03-01       Impact factor: 4.666

Review 3.  Biologic discontinuation studies: a systematic review of methods.

Authors:  Kazuki Yoshida; Yoon-Kyoung Sung; Arthur Kavanaugh; Sang-Cheol Bae; Michael E Weinblatt; Mitsumasa Kishimoto; Kazuo Matsui; Shigeto Tohma; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2013-05-30       Impact factor: 19.103

4.  Using patient-reported outcomes and PROMIS in research and clinical applications: experiences from the PCORI pilot projects.

Authors:  Clifton O Bingham; Susan J Bartlett; Peter A Merkel; Thelma J Mielenz; Paul A Pilkonis; Lauren Edmundson; Emily Moore; Rajeev K Sabharwal
Journal:  Qual Life Res       Date:  2016-02-25       Impact factor: 4.147

5.  Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis.

Authors:  S J Bartlett; A K Gutierrez; A Butanis; V P Bykerk; J R Curtis; S Ginsberg; A L Leong; A Lyddiatt; W B Nowell; A M Orbai; K C Smith; C O Bingham
Journal:  Qual Life Res       Date:  2018-05-24       Impact factor: 4.147

6.  Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Authors:  John R Kirwan; Maarten Boers; Sarah Hewlett; Dorcas Beaton; Clifton O Bingham; Ernest Choy; Philip G Conaghan; Maria-Antonietta D'Agostino; Maxime Dougados; Daniel E Furst; Francis Guillemin; Laure Gossec; Désirée M van der Heijde; Margreet Kloppenburg; Tore K Kvien; Robert B M Landewé; Sarah L Mackie; Eric L Matteson; Philip J Mease; Peter A Merkel; Mikkel Ostergaard; Lesley Ann Saketkoo; Lee Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell
Journal:  J Rheumatol       Date:  2014-03-15       Impact factor: 4.666

Review 7.  Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Authors:  Vivian P Bykerk; Elisabeth Lie; Susan J Bartlett; Rieke Alten; Annelies Boonen; Robin Christensen; Daniel E Furst; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; James E May; Pam Montie; Ana-Maria Orbai; Christoph Pohl; Marieke Scholte Voshaar; Thasia Woodworth; Clifton O Bingham; Ernest H Choy
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

Review 8.  Patient Satisfaction and Costs of Multidisciplinary Models of Care in Rheumatology: a Review of the Recent Literature.

Authors:  Jill Hall; K Julia Kaal; Junho Lee; Ross Duncan; Nicole Tsao; Mark Harrison
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

Review 9.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  What Does the Patient Global Health Assessment in Rheumatoid Arthritis Really Tell Us? Contribution of Specific Dimensions of Health-Related Quality of Life.

Authors:  Ethan T Craig; Jamie Perin; Scott Zeger; Jeffrey R Curtis; Vivian P Bykerk; Clifton O Bingham; Susan J Bartlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.